MPM BioVentures 2018 GP LLC, 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 115,280 shares at $27.64 ($3.3M) on 2021-09-13, disclosed to the SEC on 2021-09-13.
Scheduled sale ($3.3M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.97 | 22,725 | $658K | 20.2% |
| 2 | $28.97 | 22,725 | $658K | 20.2% |
| 3 | $27.86 | 6,760 | $188K | 5.8% |
| 4 | $27.86 | 6,760 | $188K | 5.8% |
| 5 | $28.73 | 6,771 | $195K | 6.0% |
| 6 | $28.73 | 6,771 |
| $195K |
| 6.0% |
| 7 | $27.64 | 21,384 | $591K | 18.1% |
| 8 | $27.64 | 21,384 | $591K | 18.1% |
| Total | $28.32 avg | 115,280 | $3.3M | 100% |
| Filing → |
| ITOS | SELL | 2022-01-06 | $12.5M | — | Filing → |
| ITOS | SELL | 2021-10-18 | $939K | — | Filing → |
| ITOS | SELL | 2021-10-14 | $2.3M | — | Filing → |